BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou S, Zeng S, Shu Y. Drug-Drug Interactions at Organic Cation Transporter 1. Front Pharmacol 2021;12:628705. [PMID: 33679412 DOI: 10.3389/fphar.2021.628705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 McGrane I, Spina E, Hiemke C, de Leon J. Pharmacokinetic drug interactions with oral haloperidol in adults: dose correction factors from a combined weighted analysis. Expert Opin Drug Metab Toxicol 2022;18:135-49. [PMID: 35331064 DOI: 10.1080/17425255.2022.2057297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mocking TAM, Sijben HJ, Vermeulen YW, IJzerman AP, Heitman LH. MPP+-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition. Int J Mol Sci 2022;23:1203. [PMID: 35163125 DOI: 10.3390/ijms23031203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cahua-Pablo JÁ, Gómez-Zamudio JH, Reséndiz-Abarca CA, Tello-Flores VA, Eulogio-Metodio Y, Ramírez-Vargas MA, Cruz M, Del Carmen Alarcón-Romero L, Matia-García I, Marino-Ortega LA, Zubillaga-Guerrero MI, Flores-Alfaro E. Genetic variants in SLC22A1 are related to serum lipid levels in Mexican women. Lipids 2021. [PMID: 34927264 DOI: 10.1002/lipd.12334] [Reference Citation Analysis]
4 Geng YJ, Madonna R, Hermida RC, Smolensky MH. Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions. Curr Res Pharmacol Drug Discov 2021;2:100025. [PMID: 34909660 DOI: 10.1016/j.crphar.2021.100025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter. Int J Mol Sci 2021;22:12995. [PMID: 34884800 DOI: 10.3390/ijms222312995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Bönisch H. Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications. Handb Exp Pharmacol 2021;266:119-67. [PMID: 34495395 DOI: 10.1007/164_2021_516] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]